Medicenna Therapeutics (MDNA) Stock Price, News & Analysis

Company Overview

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.

Key Stats

• Today's Range: C$1.27 to C$1.36
• 50-Day Range: C$1.29 to C$1.99
• 52-Week Range: C$0.41 to C$2.98
• Volume: 52,690 shs
• Average Volume: 66,058 shs
• Market Capitalization: C$100.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDNA Stock Analysis - Frequently Asked Questions

How have MDNA shares performed this year?

Medicenna Therapeutics' stock was trading at C$1.65 at the beginning of 2025. Since then, MDNA shares have decreased by 20.0% and is now trading at C$1.32.
View the best growth stocks for 2025 here.

How do I buy shares of Medicenna Therapeutics?

Shares of MDNA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Medicenna Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicenna Therapeutics investors own include Manulife Financial (MFC), Gilead Sciences (GILD), OPKO Health (OPK), Air Canada (AC), Athersys (ATHX), Birchcliff Energy (BIR) and Canadian Natural Resources (CNQ).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:MDNA
• CUSIP: N/A
• CIK: N/A
• Web: www.medicenna.com
• Phone: +1-403-6807898
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-26,240,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -105.43%
• Return on Assets: -32.80%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 2.51
• Quick Ratio: 4.65

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$1.15 per share
• Price / Cash Flow: 1.15
• Book Value: C$0.30 per share
• Price / Book: 4.40

Miscellaneous

• Outstanding Shares: 76,430,000
• Free Float: N/A
• Market Cap: C$100.89 million
• Optionable: Not Optionable
• Beta: 1.21